FUNDC1 and cholangiocarcinoma: Figure 1 demonstrates that in 34 cancer types, FUNDC1 was significantly upregulated by comparing it with the related normal tissues, such as invasive breast carcinoma (BRCA), bladder urothelial carcinoma (BLCA), cholangiocarcinoma (CHOL), head and neck squamous cell carcinoma (HNSC), esophageal carcinoma (ESCA), colon adenocarcinoma (COAD), kidney chromophobe (KICH), liver hepatocellular carcinoma (LIHC), lung squamous cell carcinoma (LUSC), thyroid carcinoma (THCA), lung adenocarcinoma (LUAD), and stomach adenocarcinoma (STAD).